These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 18576149)

  • 1. Neurotoxicity of prion peptides on cultured cerebellar neurons.
    Ciccotosto GD; Cappai R; White AR
    Methods Mol Biol; 2008; 459():83-96. PubMed ID: 18576149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurotoxicity of Prion Peptides on Cultured Cerebellar Neurons.
    Ciccotosto GD; Jana M; Cappai R
    Methods Mol Biol; 2017; 1658():147-165. PubMed ID: 28861789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prion protein peptides: optimal toxicity and peptide blockade of toxicity.
    Brown DR
    Mol Cell Neurosci; 2000 Jan; 15(1):66-78. PubMed ID: 10662506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prion protein-deficient neurons reveal lower glutathione reductase activity and increased susceptibility to hydrogen peroxide toxicity.
    White AR; Collins SJ; Maher F; Jobling MF; Stewart LR; Thyer JM; Beyreuther K; Masters CL; Cappai R
    Am J Pathol; 1999 Nov; 155(5):1723-30. PubMed ID: 10550328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A neurotoxic and gliotrophic fragment of the prion protein increases plasma membrane microviscosity.
    Salmona M; Forloni G; Diomede L; Algeri M; De Gioia L; Angeretti N; Giaccone G; Tagliavini F; Bugiani O
    Neurobiol Dis; 1997; 4(1):47-57. PubMed ID: 9258911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurotoxicity of the putative transmembrane domain of the prion protein.
    Haïk S; Peyrin JM; Lins L; Rosseneu MY; Brasseur R; Langeveld JP; Tagliavini F; Deslys JP; Lasmézas C; Dormont D
    Neurobiol Dis; 2000 Dec; 7(6 Pt B):644-56. PubMed ID: 11114262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zinc, copper, and carnosine attenuate neurotoxicity of prion fragment PrP106-126.
    Kawahara M; Koyama H; Nagata T; Sadakane Y
    Metallomics; 2011 Jul; 3(7):726-34. PubMed ID: 21442127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurotoxic prion protein (PrP) fragment 106-126 requires the N-terminal half of the hydrophobic region of PrP in the PrP-deficient neuronal cell line.
    Sakudo A; Nakamura I; Lee DC; Saeki K; Ikuta K; Onodera T
    Protein Pept Lett; 2007; 14(1):1-6. PubMed ID: 17266643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo neurotoxicity of prion protein oligomers.
    Simoneau S; Rezaei H; Salès N; Kaiser-Schulz G; Lefebvre-Roque M; Vidal C; Fournier JG; Comte J; Wopfner F; Grosclaude J; Schätzl H; Lasmézas CI
    PLoS Pathog; 2007 Aug; 3(8):e125. PubMed ID: 17784787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prion protein aggregation and neurotoxicity in cortical neurons.
    Melo JB; Agostinho P; Oliveira CR
    Ann N Y Acad Sci; 2007 Jan; 1096():220-9. PubMed ID: 17405933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of the 5-lipoxygenase pathway in the neurotoxicity of the prion peptide PrP106-126.
    Stewart LR; White AR; Jobling MF; Needham BE; Maher F; Thyer J; Beyreuther K; Masters CL; Collins SJ; Cappai R
    J Neurosci Res; 2001 Sep; 65(6):565-72. PubMed ID: 11550224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apoptosis-mediated neurotoxicity induced by beta-amyloid and PrP fragments.
    Forloni G; Bugiani O; Tagliavini F; Salmona M
    Mol Chem Neuropathol; 1996; 28(1-3):163-71. PubMed ID: 8871955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The hydrophobic core sequence modulates the neurotoxic and secondary structure properties of the prion peptide 106-126.
    Jobling MF; Stewart LR; White AR; McLean C; Friedhuber A; Maher F; Beyreuther K; Masters CL; Barrow CJ; Collins SJ; Cappai R
    J Neurochem; 1999 Oct; 73(4):1557-65. PubMed ID: 10501201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered expression of the prion gene in rat astrocyte and neuron cultures treated with prion peptide 106-126.
    Ning ZY; Zhao DM; Liu HX; Yang JM; Han CX; Cui YL; Meng LP; Wu CD; Liu ML; Zhang TX
    Cell Mol Neurobiol; 2005 Dec; 25(8):1171-83. PubMed ID: 16388330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p75(NTR) activation of NF-kappaB is involved in PrP106-126-induced apoptosis in mouse neuroblastoma cells.
    Bai Y; Li Q; Yang J; Zhou X; Yin X; Zhao D
    Neurosci Res; 2008 Sep; 62(1):9-14. PubMed ID: 18602709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo and in vitro neurotoxicity of the human prion protein (PrP) fragment P118-135 independently of PrP expression.
    Chabry J; Ratsimanohatra C; Sponne I; Elena PP; Vincent JP; Pillot T
    J Neurosci; 2003 Jan; 23(2):462-9. PubMed ID: 12533606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small stress molecules inhibit aggregation and neurotoxicity of prion peptide 106-126.
    Kanapathipillai M; Ku SH; Girigoswami K; Park CB
    Biochem Biophys Res Commun; 2008 Jan; 365(4):808-13. PubMed ID: 18039468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reorganization of prion protein membrane environment during low potassium-induced apoptosis in primary rat cerebellar neurons.
    Rivaroli A; Prioni S; Loberto N; Bettiga A; Chigorno V; Prinetti A; Sonnino S
    J Neurochem; 2007 Dec; 103(5):1954-67. PubMed ID: 17854348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection of cerebellar granule cells by tocopherols and tocotrienols against methylmercury toxicity.
    Shichiri M; Takanezawa Y; Uchida K; Tamai H; Arai H
    Brain Res; 2007 Nov; 1182():106-15. PubMed ID: 17949699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bee venom phospholipase A2 prevents prion peptide induced-cell death in neuronal cells.
    Jeong JK; Moon MH; Bae BC; Lee YJ; Seol JW; Park SY
    Int J Mol Med; 2011 Nov; 28(5):867-73. PubMed ID: 21701769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.